Close Menu

NEW YORK (GenomeWeb) – HTG Molecular today went public in the US, offering 3,570,000 shares of common stock at an initial public offering price of $14 per share.

The Tucson, Arizona-based molecular diagnostics firm expects to raise net proceeds of approximately $44.4 million, which could rise to $51.4 million if the underwriters exercise their overallotment option of 535,500 shares within 30 days of the offering. Canaccord Genuity, Leerink Partners, and JMP Securities are the underwriters on the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.